EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Liquid Biopsy for Cerebral Aneurysms: Circulating RNA as Diagnostic and Prognostic Tools—A Systematic Review of Current Evidence and Perspectives

Matteo Palermo iD, Alessandro Olivi, Carmelo Lucio Sturiale iD

Cells · 2025

DOI: 10.3390/cells14191525 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cells, 2025. Verfasst von Matteo Palermo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Fondazione Policlinico Universitario A.Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rom…. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracranial aneurysms (IAs) are potentially devastating cerebrovascular lesions, and predicting rupture risk remains a major clinical challenge. Conventional radiological and clinical scores offer only partial risk stratification, highlighting the need for complementary approaches. Liquid biopsy represents a promising non-invasive strategy to identify circulating biomarkers that reflect aneurysm biology and instability. We conducted a systematic review according to PRISMA 2020 guidelines, screening PubMed, Scopus, and Web of Science up to August 2025. Forty-eight eligible studies, encompassing 3515 IA patients, evaluated circulating RNA species, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in serum, plasma, blood, or cerebrospinal fluid. Multiple candidates emerged as consistently dysregulated: upregulation of miR-21, miR-126, and miR-200a-3p, and downregulation of miR-143 and let-7b-5p were recurrently observed across independent cohorts. LncRNAs, such as MALAT1 and MIAT, and circRNAs, including circ_0000690 and circ_0021001, demonstrated diagnostic and prognostic potential, with some correlating with rupture status and clinical severity indices. Despite encouraging findings, heterogeneity in study design, sample handling, and analytic methods limits reproducibility. Large-scale, multicenter validation studies are essential to translate these biomarkers into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial AneurysmCell-Free Nucleic AcidsHumansLiquid BiopsyPrognosisBiomarkersMicroRNAsRNA, CircularRNA, Long Noncoding

Stichwörter der Autor:innen

biomarkercircRNAintracranial aneurysmliquid biopsylncRNAmicroRNA

Substanzen

BiomarkersCell-Free Nucleic AcidsMicroRNAsRNA, CircularRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Neurosurgery, Fondazione Policlinico Universitario A.Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.

ORCID-Profile: Matteo Palermo, Carmelo Lucio Sturiale

Zitieren

APA

Palermo, M., Olivi, A., & Sturiale, C. L. (2025). Liquid Biopsy for Cerebral Aneurysms: Circulating RNA as Diagnostic and Prognostic Tools—A Systematic Review of Current Evidence and Perspectives. Cells. https://doi.org/10.3390/cells14191525

Vancouver

Palermo M, Olivi A, Sturiale CL. Liquid Biopsy for Cerebral Aneurysms: Circulating RNA as Diagnostic and Prognostic Tools—A Systematic Review of Current Evidence and Perspectives. Cells. 2025. doi:10.3390/cells14191525

BibTeX
@article{Palermo2025,
  author = {Palermo, Matteo and Olivi, Alessandro and Sturiale, Carmelo Lucio},
  title = {Liquid Biopsy for Cerebral Aneurysms: Circulating RNA as Diagnostic and Prognostic Tools—A Systematic Review of Current Evidence and Perspectives},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14191525}
}
Kostenlos starten →